Fluoptics in the spotlight

Fluoptics has carved out the top slot on Europe’s real-time fluorescence imaging solutions market. The company has implemented more than 100 of its Fluobeam^® non-invasive surgical-assistance systems in sixteen countries. Fluoptics’ technology is currently the only one in the world capable of generating images of parathyroid glands using light during tricky thyroid surgery—ultimately improving patient outcomes.

The company, founded in 2009, is located on the MINATEC campus. Fluoptics reported revenue growth of 80% last year and is pursuing its international business development strategy. With a Boston, MA (United States) office already open, the company is now setting its sights on Asia, with recent distribution agreements signed with partners in Taiwan and Thailand.

Contact: odile.allard@fluoptics.com

Facebook

Twitter